Other Clinical Trial - CRPS - Diagnostics, Pathophysiological Mechanisms,

Status Active, not recruiting

Clinical Trial Summary

This is a sham controlled, randomized, double-blind, navigated repetitive Transcranial Magnetic Stimulation (nrTMS) study for the treatment of complex regional pain syndrome (CRPS types 1 and 2). The investigators study factors that may contribute to development, maintenance, or treatment responses with clinical, sleep, and psychiatric questionnaires and clinical examinations, quantitative sensory testing and neurophysiologic recordings, genetics, and MRI techniques.

Clinical Trial Description

rTMS hypothetically disrupts the default networks related to chronic pain and renders the brain more susceptible to drugs, rehabilitation, or cognitive behavioral therapy. In addition, there is experimental evidence that rTMS releases factors that are involved in endogenous top-down modulation of pain and neural plasticity. Thus, the analgesic effect of rTMS may be mediated via enforcing endogenous pain control systems at the brain level, in addition to its effects on neuroplastic effects. For active, navigated stimulation targets the investigators have the parietal opercular cortex overlying the secondary somatosensory cortex ("S2") and the primary motor cortex (M1). The investigators randomize participants to first receive nrTMS to the right "S2" or sham stimulation. After ten sessions the investigators follow up the participants up to three months. At three months, if the average pain is ≥5/10 in numeric rating scale (NRS), the participant is offered an active, open nrTMS treatment phase depending on which treatment the participant first received. If the participant benefits from the open label treatment, a maintenance therapy is offered (6 months with gradually reducing nrTMS treatment frequency). The symptoms and quality of life are followed with questionnaires and diaries. After the maintenance period, the RN calls a structured interview at 1, 3, and 6 months. ;

Study Design

Related Conditions & MeSH terms

Complex Regional Pain Syndrome of Upper Limb (Disorder)
Complex Regional Pain Syndromes
Reflex Sympathetic Dystrophy
Syndrome
Transcranial Magnetic Stimulation

Clinical Trial Details

NCT number	NCT04439669
Study type	Interventional
Source	Helsinki University Central Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	August 28, 2017
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04927364` - Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder	N/A
Recruiting	`NCT06193278` - Individual Neuromodulation for PDS	N/A
Recruiting	`NCT05973019` - rTMS Improves Functions in Spinocerebellar Ataxia	N/A
Completed	`NCT05074524` - Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings	N/A
Recruiting	`NCT05889117` - Brain Stimulation for Concussion	N/A
Recruiting	`NCT03974659` - Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients	N/A
Recruiting	`NCT05613686` - Theta Burst Stimulation for Motor Recovery	N/A
Completed	`NCT04014491` - The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome	N/A
Recruiting	`NCT05914038` - Individualized rTMS for Motor Recovery in Stroke Patients	N/A
Recruiting	`NCT06084455` - TMS-evoked Potentials During Aerobic Exercise	N/A
Completed	`NCT05566444` - TMS-evoked Potentials During Heat Pain	N/A
Enrolling by invitation	`NCT04313530` - TMS Treatment in Multiple System Atrophy With Fatigue	N/A
Completed	`NCT04209309` - Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal	N/A
Terminated	`NCT04486222` - Accelerated Bilateral rTMS on Geriatric Depression	N/A
Recruiting	`NCT05192759` - Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait	N/A
Recruiting	`NCT05467657` - Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke	N/A
Recruiting	`NCT05896332` - rTMS in Older Adults With MCI and AUD	Phase 1
Recruiting	`NCT04727177` - Precision-targeted Transcranial Magnetic Stimulation in the Treatment of Primary Dystonia	Early Phase 1
Recruiting	`NCT04906603` - Theta Burst Stimulation for Headaches After Traumatic Brain Injury	N/A
Recruiting	`NCT03590327` - Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

CRPS - Diagnostics, Pathophysiological Mechanisms, and Response to Treatment With Noninvasive Brain Stimulation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms